UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 178

Sortiert nach

Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors

Stem cells (Dayton, Ohio), 2011-06, Vol.29 (6), p.913-919

2011

Volltextzugriff (PDF)

Actin‐binding protein filamin A is displayed on the surface of human neuroblastoma cells

Cancer science, 2006-12, Vol.97 (12), p.1359-1365

2006

Volltextzugriff (PDF)

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

Gynecologic oncology, 2015-10, Vol.139 (1), p.17-22

2015

Volltextzugriff (PDF)

Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties

International journal of radiation oncology, biology, physics, 2021-06, Vol.110 (2), p.322-327

2021

Volltextzugriff (PDF)

Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study

Journal of clinical oncology, 2020-01, Vol.38 (3), p.214-222

2020

Volltextzugriff (PDF)

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

The New England journal of medicine, 2023-04, Vol.388 (17), p.1547-1558

2023

Volltextzugriff (PDF)

Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial

JAMA oncology, 2021-03, Vol.7 (3), p.421

2021

Volltextzugriff (PDF)

Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405

Journal of clinical oncology, 2019-10, Vol.37 (29), p.2620-2631

2019

Volltextzugriff (PDF)

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer

Journal of clinical oncology, 2017-10, Vol.35 (30), p.3391-3400

2017

Volltextzugriff (PDF)

Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer

PloS one, 2013-03, Vol.8 (3), p.e54014

2013

Volltextzugriff (PDF)

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

Journal of clinical oncology, 2016-07, Vol.34 (20), p.2325-2332

2016

Volltextzugriff (PDF)

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study

The lancet oncology, 2018-04, Vol.19 (4), p.486-496

2018

Volltextzugriff (PDF)

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

The New England journal of medicine, 2017-02, Vol.376 (5), p.417-428

2017

Volltextzugriff (PDF)

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

Journal of immunotherapy (1997), 2019-05, Vol.42 (4), p.126

2019

Volltextzugriff (PDF)

Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT

Annals of nuclear medicine, 2017-10, Vol.31 (8), p.623-628

2017

Volltextzugriff (PDF)

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Journal of clinical oncology, 2019-04, Vol.37 (12), p.946-953

2019

Volltextzugriff (PDF)

2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines

Journal of clinical oncology, 2000-10, Vol.18 (20), p.3558-3585

2000

Volltextzugriff (PDF)

Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery

Journal of thoracic oncology, 2024-03, Vol.19 (3), p.476-490

2024

Volltextzugriff (PDF)

Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

JAMA oncology, 2024-03, Vol.10 (3), p.342

2024

Volltextzugriff (PDF)

FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer

Breast cancer research : BCR, 2023-08, Vol.25 (1), p.99-99, Article 99

2023

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

ThemaCancer Research

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(162)

Publikationsform

Artikel
(178)

Sprache

Englisch
(178)
Japanisch
(30)

Erscheinungsjahr

n.n

Thema

Science & Technology
(177)
Life Sciences & Biomedicine
(176)
Humans
(149)
Female
(93)
Male
(86)
Middle Aged
(85)
Aged
(78)
Adult
(68)
Biological And Medical Sciences
(66)
Medical Sciences
(66)
Tumors
(41)
Aged, 80 And Over
(31)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(31)
Chemotherapy
(29)
Pharmacology. Drug Treatments
(28)
Treatment Outcome
(26)
Prognosis
(25)
Antineoplastic Agents
(24)
Radiology, Nuclear Medicine & Medical Imaging
(24)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors

Actin‐binding protein filamin A is displayed on the surface of human neuroblastoma cells

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties

Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial

Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer

Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT

Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines

Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery

Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer

Aktive Filter

Suchergebnisse filtern